Educate your patients on COVID-19 antivirals: Professor Michael Kidd
With cases surging across Australia, there is concern vulnerable patients might easily miss the five-day window of opportunity to be treated, experts say
GPs are being urged to proactively flag the availability of COVID-19 antiviral treatments with their at-risk patients to ensure those who could benefit do not miss out on the potentially life-saving drugs.
Deputy Chief Medical Officer Professor Michael Kidd says patients need to know about the drugs’ benefits so they can get tested and treated in a timely way.
